Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/51222
Title: | Endoscopic therapeutic options for type 2 diabetes |
Authors: | MOURA, E. G. H. De; ORSO, I. R. B.; MARTINS, B. C.; LOPES, G. S. |
Citation: | De Moura, E. G. H.; Orso, I. R. B.; Martins, B. C.; Lopes, G. S.. Endoscopic therapeutic options for type 2 diabetes. In: . OBESITY AND DIABETES: SPRINGER INTERNATIONAL PUBLISHING, 2015. p.131-142. |
Abstract: | The global obesity epidemic is expected to worsen with a concomitant increase in the comorbid conditions. Obesity is a major risk factor for type 2 diabetes, and it is not surprising that the global prevalence of this disease continues to increase. Given the emerging role of endoscopic procedures in the treatment of obesity and rapid changes in endoscopic technologies and techniques, this review considers the current state of endoscopic management of obesity and type 2 diabetes. Endoluminal interventions performed entirely through the gastrointestinal tract by using endoscopic devices offer the potential for an outpatient weight loss procedure that may be safer, less invasive, and more cost-effective, compared to current surgical approaches. Endoscopic techniques attempt to mimic some of the anatomic features of bariatric surgery and rely on gastric restriction and/or duodenal exclusion. In this chapter we will describe the two endoscopic methods that have much endorsement of the literature in relation to type 2 diabetes and are in current clinical use-the intragastric balloon and the duodenojejunal bypass liner. © Springer International Publishing Switzerland 2015. |
Appears in Collections: | Livros e Capítulos de Livros - HC/ICESP Livros e Capítulos de Livros - HC/ICHC Livros e Capítulos de Livros - LIM/35 Livros e Capítulos de Livros - ODS/03 |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.